Champions Oncology Inc (OTCMKTS:CSBR) President Ronnie Morris bought 9,537 shares of the company’s stock in a transaction that occurred on Monday, October 10th. The shares were bought at an average cost of $1.66 per share, for a total transaction of $15,831.42. Following the completion of the acquisition, the president now owns 1,026,347 shares of the company’s stock, valued at $1,703,736.02. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Ronnie Morris also recently made the following trade(s):
- On Tuesday, September 20th, Ronnie Morris acquired 3,000 shares of Champions Oncology stock. The stock was acquired at an average cost of $1.58 per share, for a total transaction of $4,740.00.
Shares of Champions Oncology Inc (OTCMKTS:CSBR) traded up 0.60% during mid-day trading on Tuesday, reaching $1.67. The company’s stock had a trading volume of 28,114 shares. The company’s 50 day moving average price is $1.68 and its 200-day moving average price is $2.58. The company’s market capitalization is $18.31 million. Champions Oncology Inc has a 1-year low of $1.11 and a 1-year high of $5.49.
Champions Oncology (OTCMKTS:CSBR) last released its quarterly earnings data on Friday, September 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. The firm earned $3.70 million during the quarter.
Champions Oncology Company Profile
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with MarketBeat.com's FREE daily email newsletter.